A Study of Fruquintinib in Combination With Irinotecan and Capecitabine for the Second-line Treatment of Patients

Clinical trial NCT06169202 · UNKNOWN

Trial details

NCT number: NCT06169202
Sponsor: China Medical University, China
Status: UNKNOWN
Study type: OBSERVATIONAL

Fruquintinib Irinotecan Capecitabine Gastrointestinal Tumours

Start date: 2023-06-01
Primary completion: 2025-04-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.